Tai-An Lin
Direttore Tecnico/Scientifico/R&S presso SPRINGWORKS THERAPEUTICS, INC.
Patrimonio netto: 1 M $ in data 30/06/2024
Provenienza dei contatti di primo grado di Tai-An Lin
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Biotechnology | 17 | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.
14
| Subsidiary | Pharmaceuticals: Major | 14 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Tai-An Lin tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Sales & Marketing Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
SpringWorks Therapeutics LLC
 SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | Biotechnology | Director/Board Member Director/Board Member Chairman Chief Executive Officer | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Compliance Officer Corporate Officer/Principal | |
| The Pennsylvania State University | College/University | Undergraduate Degree Undergraduate Degree | |
| Harvard Medical School | College/University | Director/Board Member Doctorate Degree | |
| Brandeis University | College/University | Undergraduate Degree Undergraduate Degree | |
| TYRA BIOSCIENCES, INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
| Villanova University | College/University | Undergraduate Degree Undergraduate Degree | |
Bayer HealthCare
 Bayer HealthCare Medical/Nursing ServicesHealth Services Part of Bayer AG, Bayer HealthCare is a company that provides medical care and animal health care services. The company is based in Tarrytown, NY. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Pharmaceuticals: Major | Chief Operating Officer Director/Board Member | |
| ABBVIE INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Gennao Bio, Inc.
 Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Gennao Bio, Inc. is a privately-held genetic medicines company that is developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing its proprietary gene monoclonal antibody (gmab) platform technology. The company is based in Pennington, NJ. The company's gmab technology uses a novel, cell-penetrating antibody to non-covalently bind to, and deliver therapeutic levels of a wide variety of nucleic acid payloads, to select cells. Gennao Bio is initially focusing on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases. The company's non-viral delivery platform offers significant advantages over traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and dose optimization, and can be easily and affordably manufactured. The company was founded in 2020 by Bruce Turner, Elias Quijano, Peter M. Glazer, Stephen P. Squinto. Christopher M. Duke has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
| ERASCA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Accent Therapeutics, Inc.
 Accent Therapeutics, Inc. BiotechnologyHealth Technology Accent Therapeutics, Inc. operates as a biopharmaceutical company which develops treatments for cancer patients. The company was founded by Howard Y. Chang, Chuan He and Robert A. Copeland in September 2017 and is headquartered in Lexington, MA. | Biotechnology | Director/Board Member | |
Onc.ai, Inc.
 Onc.ai, Inc. Packaged SoftwareTechnology Services Onc.ai, Inc. is a digital health company that is privately held and is developing a precision oncology care management platform. The company is based in San Carlos, CA. The company aims to transform clinical decision making and is backed by premier investment firms such as the Blue Venture Fund, MassMutual Alternative Investments, and Accomplice, among others. The company is building a pipeline of physician-centered products to fulfill the potential of precision oncology. The company was founded by Akshay Nanduri, who has been the CEO since incorporation. | Packaged Software | Director/Board Member | |
| Case Western Reserve University School of Medicine | College/University | Doctorate Degree | |
Eli Lilly & Co. Ltd.
 Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Eli Lilly & Co. Ltd. provides pharmaceutical health care solutions. It provide products for cardiovascular, dermatology, diabetes, endocrine, musculoskeletal, neuroscience, oncology and urology. The company was incorporated on April 9, 1963 and is headquartered in Basingstoke, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
Chamber of Commerce of The United States of America
 Chamber of Commerce of The United States of America Miscellaneous Commercial ServicesCommercial Services The Chamber of Commerce of The United States of America provides information on how businesses can adapt their workforce development and management strategies to deal with the changing labor market. The non-profit company is based in Washington and has subsidiaries in the United States. The Chamber of Commerce of The United States of America is the world's largest business organization, advocating, connecting, informing, and fighting for business growth and success. The American company was founded by Michael Scown, and Suzanne P. Clark has been the CEO of the company since 2014. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Cranfield School of Management | College/University | Graduate Degree | |
| University College London | College/University | Undergraduate Degree | |
| European Pharmaceutical Market Research Association | Director/Board Member | ||
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Director/Board Member | |
| Merck Serono Co., Ltd. | President | ||
Clarus Ventures LLC
 Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Pharmaceuticals: Major | Chairman | |
Anthos Therapeutics, Inc.
 Anthos Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Anthos Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops and commercializes innovative therapies for high-risk cardiovascular patients. It offers MAA868, an antibody directed at Factor XI and XIa, key components of the intrinsic coagulation pathway. The company was founded by Paris Panayiotopoulos, Ari Brettman and Jonathan E. Freeman in 2018 and is headquartered in Cambridge, MA. | Pharmaceuticals: Other | Founder | |
FerGene, Inc.
 FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Biotechnology | Chairman | |
Blackstone Life Sciences Advisors LLC
 Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences Advisors LLC (Blackstone Life Sciences) is a private equity subsidiary of Blackstone, Inc. founded in 2017. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
AvenCell Therapeutics, Inc.
 AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Pharmaceuticals: Major | Founder | |
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Arch Oncology, Inc.
 Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Miscellaneous Commercial Services | Chief Executive Officer | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| IDEAYA BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| KINEMED INC | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal | |
| PASSAGE BIO, INC. | Biotechnology | Director/Board Member | |
| MODERNA, INC. | Biotechnology | Corporate Officer/Principal | |
| ARS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Investor Relations Contact |
Statistiche
Distribuzione geografica
| Stati Uniti | 44 |
| Regno Unito | 4 |
| Germania | 2 |
| Svizzera | 2 |
| Giappone | 2 |
Settori
| Health Technology | 33 |
| Consumer Services | 8 |
| Commercial Services | 5 |
| Finance | 4 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 84 |
| Corporate Officer/Principal | 78 |
| Independent Dir/Board Member | 38 |
| Chief Tech/Sci/R&D Officer | 24 |
| Undergraduate Degree | 22 |
Contatti più connessi
| Insiders | |
|---|---|
| Daniel Lynch | 32 |
| Freda Lewis-Hall | 29 |
| Paris Panayiotopoulos | 18 |
| Elizabeth Jobes | 18 |
| Alan Fuhrman | 17 |
| Julie Hambleton | 15 |
| Saqib Islam | 15 |
| Maria Rivas | 14 |
| Alise Reicin | 13 |
| Frank Perier | 13 |
| Joseph Leveque | 12 |
| Ravi Kiron | 11 |
| Carlos Alban | 10 |
| Badreddin Edris | 9 |
| Rehan Verjee | 7 |
- Borsa valori
- Insiders
- Tai-An Lin
- Connessioni Società
